Home »
RECENT NEWS

Visit the WFH News page to find out more about the events and developments that are making a difference today.

HA-Bayer---Usenov-Nursultan---Header

WFH Humanitarian Aid Program: prophylaxis supports a dream in Kyrgyzstan

The WFH Humanitarian Aid Program works with national member organizations (NMOs) and hemophilia treatment centres (HTCs) around the world to support people with bleeding disorders (PWBDs) so that they can live more normal lives. The Program aims to provide sustainable care—not just one-off donations. The goal is that PWBDs can have consistent access to support so that they can live more normal lives. Usenov Nursultan is an 18-year-old from Kyrgyzstan. Thanks to WFH Humanitarian Aid Program donated treatment products, he hopes to one day become a medical doctor.

Also available in: Français Español

Nursultan has severe hemophilia A. Because he received minimal treatment as a child, he suffered from frequent bleeds, and, as a result, he has arthropathy of both knee joints. His brother also has hemophilia. Living with hemophilia—and seeing how it affected both himself and his brother—instilled in Nursultan a strong desire to try and make a difference by becoming a physician. 

Despite continuing bleeds in his knees, Nursultan was able to study hard and was accepted to medical school. His hard work continued there, and he progressed in his studies—but missed school because of bleeds in his knees. At this point, the specialists at the hemophilia treatment centre (HTC) suggested that he go on low-dose short-term secondary prophylaxis with factor concentrate—provided by the WFH Humanitarian Aid Program—to minimize further school absences. The treatment was successful: acute bleeds stopped almost entirely, and he was able to concentrate fully on his medical studies. The therapy also improved Nursultan’s quality of life drastically. The success of this prophylactic treatment in Kyrgyzstan is further proof that predictable donations can help make sustainable care possible.

Since 2015, nearly 28 million IUs of factor have been donated to Kyrgyzstan. Just over 3.3 million IUs of factor were donated in 2022 alone. To find out more about the WFH Humanitarian Aid Program, please click here.

About the WFH Humanitarian Aid Program

The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda and Japan Blood Products Organization, our Contributors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?